NO20033921D0 - Inhibitor av monoaminopptak - Google Patents

Inhibitor av monoaminopptak

Info

Publication number: NO20033921D0
Authority: NO; Norway
Prior art keywords: uptake inhibitor; monoamine uptake; monoamine; inhibitor; uptake
Prior art date: 2001-03-06

Application number

NO20033921A

Other languages

English (en)

Other versions

NO20033921L (no

Inventor

Edward Louis Mattiuz

John-Michael Sauer

William Joe Wheeler

David Taiwai Wong

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-06

Filing date

2003-09-04

Publication date

2003-09-04

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23045157&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20033921(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-09-04 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2003-09-04 Publication of NO20033921D0 publication Critical patent/NO20033921D0/no

2003-11-05 Publication of NO20033921L publication Critical patent/NO20033921L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/48—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Addiction (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Anesthesiology (AREA)
Immunology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Gynecology & Obstetrics (AREA)
Diabetes (AREA)
Child & Adolescent Psychology (AREA)
Obesity (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)

NO20033921A 2001-03-06 2003-09-04 Inhibitor av monoaminopptak NO20033921L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US27373001P	2001-03-06	2001-03-06
PCT/US2002/003385 WO2002070457A1 (en)	2001-03-06	2002-02-20	Inhibitor of monoamine uptake

Publications (2)

Publication Number	Publication Date
NO20033921D0 true NO20033921D0 (no)	2003-09-04
NO20033921L NO20033921L (no)	2003-11-05

Family

ID=23045157

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20033921A NO20033921L (no)	2001-03-06	2003-09-04	Inhibitor av monoaminopptak

Country Status (35)

Country	Link
US (2)	US20040082666A1 (no)
EP (1)	EP1379492B1 (no)
JP (1)	JP2004525912A (no)
KR (1)	KR20030092012A (no)
CN (1)	CN1229331C (no)
AP (1)	AP2003002855A0 (no)
AT (2)	AT414238B (no)
AU (1)	AU2002245385B2 (no)
BR (1)	BR0207716A (no)
CA (1)	CA2440161A1 (no)
CH (1)	CH695982A5 (no)
CZ (1)	CZ20032380A3 (no)
DE (1)	DE60226715D1 (no)
DK (1)	DK200301267A (no)
EA (1)	EA005768B1 (no)
EC (1)	ECSP034760A (no)
EE (1)	EE200300419A (no)
ES (2)	ES2201942B2 (no)
FI (1)	FI20031191L (no)
GB (1)	GB2389851B (no)
HR (1)	HRP20030710A2 (no)
HU (1)	HUP0303341A3 (no)
IL (1)	IL157779A0 (no)
LT (1)	LT5143B (no)
LU (1)	LU91038B1 (no)
LV (1)	LV13119B (no)
NO (1)	NO20033921L (no)
NZ (1)	NZ527431A (no)
OA (1)	OA12494A (no)
PL (1)	PL363840A1 (no)
SE (1)	SE526598C2 (no)
SK (1)	SK10632003A3 (no)
TR (1)	TR200705146T1 (no)
WO (1)	WO2002070457A1 (no)
ZA (1)	ZA200306882B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ527431A (en) *	2001-03-06	2005-05-27	Lilly Co Eli	Inhibitor of monoamine uptake
CA2536161A1 (en) *	2003-08-27	2005-03-10	Eli Lilly And Company	Treatment of pervasive developmental disorders with norepinephrine reuptake inhibitors
WO2005060949A2 (en) *	2003-12-12	2005-07-07	Eli Lilly And Company	Selective norepinephrine reuptake inhibitors for the treatment of hot flashes, impulse control disorders and personality change due to a general medical condition
WO2011027359A2 (en) *	2009-07-30	2011-03-10	Matrix Laboratories Ltd	Novel process for the preparation of 4-hydroxy atomoxetine
WO2012020418A1 (en)	2010-08-12	2012-02-16	Matrix Laboratories Ltd	Novel polymorphs of 4-hydroxy atomoxetine hydrochloride
DE102013022397A1 (de)	2013-12-19	2016-07-07	Metrax Gmbh	Vorrichtung zur Unterstützung eines Ersthelfers bei der Herzdruckmassage
GR1008819B (el)	2015-05-22	2016-08-01	Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων	Φαρμακευτικο σκευασμα που περιλαμβανει ατομοξετινη και μεθοδος παρασκευης αυτου
CN107935848B (zh) *	2017-11-21	2020-12-22	中国农业科学院兰州畜牧与兽药研究所	一种六茜素衍生物及其制备方法和应用
AU2019370091A1 (en) *	2018-10-31	2021-05-27	Apnimed, Inc. (Delaware)	Methods and compositions for treating sleep apnea

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4018895A (en)	1974-01-10	1977-04-19	Eli Lilly And Company	Aryloxyphenylpropylamines in treating depression
US4314081A (en) *	1974-01-10	1982-02-02	Eli Lilly And Company	Arloxyphenylpropylamines
US4194009A (en)	1974-01-10	1980-03-18	Eli Lilly And Company	Aryloxyphenylpropylamines for obtaining a psychotropic effect
FR2432500A1 (fr) *	1978-02-24	1980-02-29	Roussel Uclaf	Nouveaux derives de la benzene propanamine et leurs sels, procede de preparation et application a titre de medicaments
US5112619A (en) *	1985-11-12	1992-05-12	Eli Lilly And Company	Orally administerable sustained release pharmaceutical formulation
US4956388A (en)	1986-12-22	1990-09-11	Eli Lilly And Company	3-aryloxy-3-substituted propanamines
CA1327795C (en) *	1987-08-14	1994-03-15	Jules Freedman	Antidepressants which are aryloxy inadanamines
PH30083A (en) *	1991-02-25	1996-12-27	Lilly Co Eli	Treatment of lower urinary tract disorders
TW514634B (en)	1997-10-14	2002-12-21	Lilly Co Eli	Process to make chiral compounds
AU3219800A (en)	1999-03-29	2000-10-16	Eli Lilly And Company	Stereospecific method for preparing tomoxetine and intermediates thereof
CA2362185C (en)	1999-04-09	2009-06-02	Eli Lilly And Company	Methods for preparing 3-aryloxy-3-arylpropylamines and intermediates thereof
IL155874A0 (en) *	2000-11-15	2003-12-23	Lilly Co Eli	Treatment of anxiety disorders
NZ527431A (en) *	2001-03-06	2005-05-27	Lilly Co Eli	Inhibitor of monoamine uptake

2002
- 2002-02-20 NZ NZ527431A patent/NZ527431A/en unknown
- 2002-02-20 GB GB0323169A patent/GB2389851B/en not_active Expired - Fee Related
- 2002-02-20 ES ES200350052A patent/ES2201942B2/es not_active Expired - Fee Related
- 2002-02-20 OA OA1200300215A patent/OA12494A/en unknown
- 2002-02-20 IL IL15777902A patent/IL157779A0/xx unknown
- 2002-02-20 AT AT0904202A patent/AT414238B/de not_active IP Right Cessation
- 2002-02-20 EA EA200300978A patent/EA005768B1/ru not_active IP Right Cessation
- 2002-02-20 AT AT02713538T patent/ATE396170T1/de not_active IP Right Cessation
- 2002-02-20 CZ CZ20032380A patent/CZ20032380A3/cs unknown
- 2002-02-20 TR TR2007/05146T patent/TR200705146T1/xx unknown
- 2002-02-20 DE DE60226715T patent/DE60226715D1/de not_active Revoked
- 2002-02-20 EE EEP200300419A patent/EE200300419A/xx unknown
- 2002-02-20 PL PL02363840A patent/PL363840A1/xx not_active Application Discontinuation
- 2002-02-20 CA CA002440161A patent/CA2440161A1/en not_active Abandoned
- 2002-02-20 HU HU0303341A patent/HUP0303341A3/hu unknown
- 2002-02-20 CH CH01522/03A patent/CH695982A5/de not_active IP Right Cessation
- 2002-02-20 KR KR10-2003-7011635A patent/KR20030092012A/ko not_active Ceased
- 2002-02-20 AU AU2002245385A patent/AU2002245385B2/en not_active Ceased
- 2002-02-20 CN CNB028060253A patent/CN1229331C/zh not_active Ceased
- 2002-02-20 WO PCT/US2002/003385 patent/WO2002070457A1/en not_active IP Right Cessation
- 2002-02-20 AP APAP/P/2003/002855A patent/AP2003002855A0/en unknown
- 2002-02-20 BR BR0207716-7A patent/BR0207716A/pt not_active IP Right Cessation
- 2002-02-20 ES ES02713538T patent/ES2305221T3/es not_active Expired - Lifetime
- 2002-02-20 SK SK1063-2003A patent/SK10632003A3/sk unknown
- 2002-02-20 JP JP2002569778A patent/JP2004525912A/ja not_active Ceased
- 2002-02-20 LU LU91038A patent/LU91038B1/fr active
- 2002-02-20 EP EP02713538A patent/EP1379492B1/en not_active Revoked
- 2002-02-20 US US10/468,553 patent/US20040082666A1/en not_active Abandoned
2003
- 2003-08-11 LT LT2003075A patent/LT5143B/lt unknown
- 2003-08-25 FI FI20031191A patent/FI20031191L/fi not_active IP Right Cessation
- 2003-09-02 EC EC2003004760A patent/ECSP034760A/es unknown
- 2003-09-03 ZA ZA200306882A patent/ZA200306882B/en unknown
- 2003-09-03 SE SE0302361A patent/SE526598C2/sv not_active IP Right Cessation
- 2003-09-04 DK DK200301267A patent/DK200301267A/da not_active Application Discontinuation
- 2003-09-04 NO NO20033921A patent/NO20033921L/no not_active Application Discontinuation
- 2003-09-05 HR HR20030710A patent/HRP20030710A2/hr not_active Application Discontinuation
- 2003-09-10 LV LVP-03-100A patent/LV13119B/en unknown
2005
- 2005-05-09 US US11/125,348 patent/US7384983B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
GB2389851A (en)	2003-12-24
GB0323169D0 (en)	2003-11-05
TR200705146T1 (tr)	2008-02-21
FI20031191L (fi)	2003-08-25
HUP0303341A2 (hu)	2004-01-28
EP1379492B1 (en)	2008-05-21
CN1229331C (zh)	2005-11-30
CN1494526A (zh)	2004-05-05
LT5143B (lt)	2004-06-25
NZ527431A (en)	2005-05-27
AU2002245385B2 (en)	2007-01-18
US7384983B2 (en)	2008-06-10
PL363840A1 (en)	2004-11-29
SE526598C2 (sv)	2005-10-18
LV13119B (en)	2004-06-20
WO2002070457A1 (en)	2002-09-12
SK10632003A3 (sk)	2004-06-08
DK200301267A (da)	2003-11-06
WO2002070457A8 (en)	2004-06-03
BR0207716A (pt)	2004-03-23
AP2003002855A0 (en)	2003-08-20
US20040082666A1 (en)	2004-04-29
EE200300419A (et)	2004-02-16
GB2389851B (en)	2005-05-25
DE60226715D1 (de)	2008-07-03
IL157779A0 (en)	2004-03-28
LU91038B1 (fr)	2003-09-11
AT414238B (de)	2006-10-15
HUP0303341A3 (en)	2007-03-28
CH695982A5 (de)	2006-11-15
SE0302361D0 (sv)	2003-09-03
ES2201942A1 (es)	2004-03-16
JP2004525912A (ja)	2004-08-26
ATE396170T1 (de)	2008-06-15
LT2003075A (en)	2004-03-25
EP1379492A1 (en)	2004-01-14
ES2201942B2 (es)	2004-12-16
ES2305221T3 (es)	2008-11-01
ATA90422002A (de)	2006-01-15
SE0302361L (sv)	2003-09-03
OA12494A (en)	2006-05-24
EA200300978A1 (ru)	2004-02-26
KR20030092012A (ko)	2003-12-03
CA2440161A1 (en)	2002-09-12
HRP20030710A2 (en)	2004-08-31
US20050209341A1 (en)	2005-09-22
ECSP034760A (es)	2003-10-28
EA005768B1 (ru)	2005-06-30
CZ20032380A3 (en)	2004-03-17
ZA200306882B (en)	2004-12-03
NO20033921L (no)	2003-11-05

Publication	Publication Date	Title
CY2015028I1 (el)	2016-07-27	Ενας αναστολεας ν-ακυλοσφιγγοσινο γλυκοζυλοτρανσφερασης
DE60234125D1 (de)	2009-12-03	E inhibitoren
PT1370553E (pt)	2006-09-29	Inibidores de rhoquinase
FI20021600L (fi)	2003-03-07	Itsenivelöity pingotin
DK1425586T3 (da)	2008-02-11	Massemarkörer
NO20034045L (no)	2003-11-10	Metallproteinase-inhibitorer
IS7291A (is)	2004-06-01	Merkt kirni
DE60223654D1 (de)	2008-01-03	Resistzusammensetzung
DE60228803D1 (de)	2008-10-23	Schlaghammergerät
FI20010780A0 (fi)	2001-04-12	Parannetut koostumukset
DE60230934D1 (de)	2009-03-05	Fab-i-inhibitoren
IS6915A (is)	2003-08-15	Lyfjablanda
NO20034032D0 (no)	2003-09-11	Metallproteinase-inhibitorer
BR0210619A (pt)	2006-05-23	composição
DE60205829T2 (de)	2006-06-14	Kette
IS7081A (is)	2003-12-16	Lyfjablanda
DK1272488T3 (da)	2006-07-17	Tri-aryl-substitueret ethan-PDE4-inhibitorer
DE60204972D1 (de)	2005-08-11	Weichspülmittel
NO20033921D0 (no)	2003-09-04	Inhibitor av monoaminopptak
DE60229669D1 (de)	2008-12-11	X-2 inhibitoren
DE50204245D1 (de)	2005-10-20	Sperrklinke
DE60132468D1 (de)	2008-03-06	Alen-lanosterol zyklase inhibitoren
ITTO20020744A0 (it)	2002-08-23	Composizione
DE50214325D1 (de)	2010-05-20	Einblatt-Überkopf-Tor
DE60207874D1 (de)	2006-01-12	Weichspülmittel

Legal Events

Date	Code	Title	Description
2008-09-22	FC2A	Withdrawal, rejection or dismissal of laid open patent application